中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肿瘤相关抗原及抗体在肝癌诊断中的研究进展

王戊辰 周永宁

引用本文:
Citation:

肿瘤相关抗原及抗体在肝癌诊断中的研究进展

DOI: 10.3969/j.issn.1001-5256.2014.06.025
详细信息
  • 中图分类号: R735.7

Research progress in tumor- associated antigen antibodies for diagnosis of liver cancer

  • 摘要: 肝癌是全世界最常见的恶性肿瘤之一,虽然其治疗手段不断进步,但病死率仍居高不下。早期诊断可提高患者的生存时间,因此,亟须探索新的生物标志物以便及时诊断肝癌。当前研究的热点集中于肿瘤相关抗原(TAA)及对应的自身抗体来作为肿瘤血清学生物学标志,介绍了自身抗体的产生过程以及当前在肝癌组织中所发现的TAA组和抗-TAAs。此外,指出了这些新发现的自身抗体具有较高敏感性和特异性,将有助于肝癌的早期诊断。

     

  • [1] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.
    [2]YANG BH, ZHANG BH.Risk factors and prevention for primary liver cancer[J].J Clin Hepatol, 2012, 28 (4) :253-258. (in Chinese) 杨秉辉, 张博恒.重视肝癌的病因和预防[J].临床肝胆病杂志, 2012, 28 (4) :253-258.
    [3]MORALES M, CABRERA MA, MAESO MD, et al.Use of panitumumab in the treatment of acinar cell carcinoma of the pancreas:a case report[J].Oncol Lett, 2013, 5 (3) :969-971.
    [4]FINN OJ.Immune response as a biomarker for cancer detection and a lot more[J].N Engl J Med, 2005, 353 (12) :1288-1290.
    [5]LI J, WANG LJ, YING X, et al.Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer[J].Scand J Immunol, 2012, 75 (3) :342-349.
    [6]BALDWIN RW.Immunity to transplanted tumour:the effect of tumour extracts on the growth of homo-logous tumours in rats[J].Br J Cancer, 1955, 9 (4) :646-651.
    [7]BELOUSOV PV, KUPRASH DV, NEDOSPASOV SA, et al.Autoantibodies to tumor-associated antigens as cancer biomarkers[J].Curr Mol Med, 2010, 10 (2) :115-122.
    [8]LOILOME W, YOOYUEN S, NAMWAT N, et al.PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangio carcinoma:application for assessment of the risk group[J].Tumour Biol, 2012, 33 (6) :2289-2298.
    [9]SPIOTTO MT, RETH MA, SCHREIBER H.Genetic changes occurring in established tumors rapidly stimulate new antibody responses[J].Proc Natl Acad Sci U S A, 2003, 100 (9) :5425-5430.
    [10]CASIANO CA, MEDIAVILLA-VARELA M, TAN EM.Tumor-associated antigen arrays for the serological diagnosis of cancer[J].Mol Cell Proteomics, 2006, 5 (10) :1745-1759.
    [11]ANDERSON KS, LABAER J.The sentinel within:exploiting the immune system for cancer biomarkers[J].J Proteome Res, 2005, 4 (4) :1123-1133.
    [12]BEI R, MASUELLI L, PALUMBO C, et al.A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients:inflammation in their induction and impact on tumor growth[J].Cancer Lett, 2009, 281 (1) :8-23.
    [13]LUNA CORONELL JA, SYED P, SERGELEN K, et al.The current status of cance biomarker research using tumour-associated antigens for minimal invasive and earlycancer diagnostics[J].J Proteomics, 2012, 76:102-115.
    [14]SUZUKI A, IIZUKA A, KOMIYAMA M, et al.Identification of melanoma antigens using a Serological Proteome Approach (SERPA) [J].Cancer Genomics Proteomics, 2010, 7 (1) :17-23.
    [15] BABEL I, BARDE RAS R, DIAZ-URIARTE R, et al.Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays[J].Mol Cell Proteomics, 2009, 8 (10) :2382-2395.
    [16]KOBAYASHI S, KIM SR, IMOTO S, et al.Histopathological diagnosis of early HCC through biopsy:efficacy of victoria blue and cytokeratin 7 staining[J].Dig Dis, 2012, 30 (6) :574-579.
    [17]NIE RH, LIU YY.Application of detection of tumor markers AFP, CA125, CA199 and CEA in diagnosis and treatment for patients with hepatitis and liver cirrhosis[J].J Jilin Univ:Med Edit, 2012, 38 (1) :119-122. (in Chinese) 聂荣慧, 刘元元.肿瘤标志物AFP、CA125、CA199和CEA检测在肝炎、肝硬化患者诊断和治疗中的应用[J].吉林大学学报:医学版, 2012, 38 (1) :119-122.
    [18]ZHANG WP.Alpha-fetoprotein and liver cancer:a new understanding of an old problem[J].J Med Res, 2013, 42 (6) :3-5. (in Chinese) 章卫平.甲胎蛋白与肝癌:老问题的新认识[J].医学研究杂志, 2013, 42 (6) :3-5.
    [19] ERTLE JM, HEIDER D, WICHERT M, et al.A Combination ofα-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma[J].Digestion, 2013, 87 (2) :121-131.
    [20]MATSUBARA M, SHIRAHA H, KATAOKA J, et al.Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2012, 27 (10) :1602-1608.
    [21]CHOI JY, JUNG SW, KIM HY, et al.Diagnostic value of AFP-L3and PIVKA-II in hepatocellular carcinoma according to total-AFP[J].World J Gastroenterol, 2013, 19 (3) :339-346.
    [22]YANG Y, XIA T, LI N, et al.Combined effects of p53 and MDM2polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma[J].Protein Cell, 2013, 4 (1) :71-81.
    [23]LU M, NAKAMURA RM, DENT ED, et al.Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis[J].Am J Pathol, 2001, 159 (3) :945-953.
    [24]TAKASHIMA M, KURAMITSUY, YOKOYAMAY, et al.Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma[J].Proteomics, 2006, 6 (13) :3894-3900.
    [25]STENNER-LIEWEN F, LUO G, SAHIN U, et al.Definition of tumor-associated antigens in hepatocellular carcinoma[J].Cancer Epidemiol Biomarkers Prev, 2000, 9 (3) :285-290.
    [26]UEMURA M, NOUSO K, KOBAYASHI Y, et al.Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma[J].Cancer, 2003, 97 (10) :2474-2479.
    [27]LI L, CHEN SH, YU CH, et al.Identification of hepatocellularcarcinoma-associate dantigens and autoantibodies by serological proteome analysis combined with protein microarray[J].J Proteome Res, 2005, 7 (2) :611-620.
    [28]ZOU L, WU Y, PEI L, et al.Identification of leukemia-associated antigens in chronic myeloid leukemia by proteomic analysis[J].Leuk Res, 2005, 29 (12) :1387-1391.
    [29]CHEN Y, ZHOU Y, QIU S, et al.Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma[J].Cancer Lett, 2010, 289 (1) :32-39.
    [30]LI Y, WANG K, DAI L, et al.HapMap-based study of CIP2A gene polymorphisms and HCC susceptibility[J].Oncol Lett, 2012, 4 (2) :358-364.
    [31]SHAO Q, REN P, LI Y, et al.Autoantibodies against glucoseregulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma[J].Int J Oncol, 2012, 41 (3) :1061-1067.
    [32]AKADA J, KAMEI S, ITO A, et al.A new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patients[J].Proteome Sci, 2013, 11 (1) :33.
    [33]NAHON P, SUTTON A, RUFAT P, et al.Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis[J].Hepatology, 2009, 50 (5) :1484-1493.
    [34]TAN Y, QIN S, HOU X, et al.Proteomic-based analysis for identification of proteins involved in 5-fluorouracil resistance in hepatocellular carcinoma[J].Curr Pharm Des, 2014, 20 (1) :81-87.
  • 加载中
计量
  • 文章访问数:  2853
  • HTML全文浏览量:  14
  • PDF下载量:  576
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-06-29
  • 出版日期:  2014-06-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回